Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycaemia in beta-cell-specific calmodulin-overexpressing transgenic mice.

Source:http://linkedlifedata.com/resource/pubmed/id/15879367

Download in:

View as

General Info

PMID
15879367